Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T56510 | Target Info | |||
Target Name | Apoptosis regulator Bcl-xL (BCL-xL) | ||||
Synonyms | Bcl2like protein 1; Bcl2L1; Bcl2-L-1; Bcl-XL; Bcl-2-like protein 1; BCLX; BCL2L; Apoptosis regulator Bcl-X | ||||
Target Type | Clinical trial Target | ||||
Gene Name | BCL2L1 | ||||
Biochemical Class | B-cell lymphoma Bcl-2 | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | 6-[(8E)-8-{2-[4-(benzylcarbamoyl)-1,3-thiazol-2-yl]hydrazinylidene}-5,6,7,8-tetrahydronaphthalen-2-yl]-3-(2-phenylethoxy)pyridine-2-carboxylic acid | Ligand Info | |||
Canonical SMILES | C1CC2=C(C=C(C=C2)C3=NC(=C(C=C3)OCCC4=CC=CC=C4)C(=O)O)C(=NNC5=NC(=CS5)C(=O)NCC6=CC=CC=C6)C1 | ||||
InChI | 1S/C35H31N5O4S/c41-33(36-21-24-10-5-2-6-11-24)30-22-45-35(38-30)40-39-29-13-7-12-25-14-15-26(20-27(25)29)28-16-17-31(32(37-28)34(42)43)44-19-18-23-8-3-1-4-9-23/h1-6,8-11,14-17,20,22H,7,12-13,18-19,21H2,(H,36,41)(H,38,40)(H,42,43)/b39-29+ | ||||
InChIKey | LPGFMHLHQPZQLK-YWIBTEMISA-N | ||||
PubChem Compound ID | 155804564 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 7JGW Crystal structure of BCL-XL in complex with COMPOUND 1620116, CRYSTAL FORM 1 | ||||||
Method | X-ray diffraction | Resolution | 1.30 Å | Mutation | No | [1] |
PDB Sequence |
GPLGSMSQSN
5 RELVVDFLSY15 KLSQKGYSWS25 QMAAVKQALR91 EAGDEFELRY101 RRAFSDLTSQ 111 LHITPGTAYQ121 SFEQVVNELF131 RDGVNWGRIV141 AFFSFGGALC151 VESVDKEMQV 161 LVSRIAAWMA171 TYLNDHLEPW181 IQENGGWDTF191 VELYG
|
|||||
|
ALA93
3.437
GLU96
4.089
PHE97
3.538
TYR101
3.574
ARG102
2.921
PHE105
3.457
SER106
2.831
ASP107
3.130
LEU108
3.387
THR109
3.709
GLU129
3.748
|
|||||
PDB ID: 7JGV CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH COMPOUND 1620116, CRYSTAL FORM 2 | ||||||
Method | X-ray diffraction | Resolution | 2.05 Å | Mutation | No | [1] |
PDB Sequence |
MSQSNRELVV
10 DFLSYKLSQK20 GYSWSQMAAV86 KQALREAGDE96 FELRYRRAFS106 DLTSQLHITP 116 GTAYQSFEQV126 VNELFRDGVN136 WGRIVAFFSF146 GGALCVESVD156 KEMQVLVSRI 166 AAWMATYLND176 HLEPWIQENG186 GWDTFVELYG196
|
|||||
|
ALA93
3.589
GLU96
4.022
PHE97
3.617
TYR101
2.587
ARG102
3.117
PHE105
3.542
SER106
2.881
ASP107
3.079
LEU108
3.643
THR109
3.559
GLU129
3.682
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Optimization of Benzothiazole and Thiazole Hydrazones as Inhibitors of Schistosome BCL-2. ACS Infect Dis. 2021 May 14;7(5):1143-1163. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.